Literature DB >> 21720156

Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin.

Adam Whaley-Connell1, Javad Habibi, Zachary Panfili, Melvin R Hayden, Sarika Bagree, Ravi Nistala, Safwan Hyder, Bennett Krueger, Vincent Demarco, Lakshmi Pulakat, Carlos M Ferrario, Alan Parrish, James R Sowers.   

Abstract

BACKGROUND/AIMS: Angiotensin (Ang) II contributes to tubulointerstitial fibrosis. Recent data highlight mammalian target of rapamycin (mTOR)/S6 kinase 1 (S6K1) signaling in tubulointerstitial fibrosis; however, the mechanisms remain unclear. Thereby, we investigated the role of Ang II on mTOR/S6K1-dependent proximal tubule (PT) injury, remodeling, and fibrosis.
METHODS: We utilized young transgenic Ren2 rats (R2-T) and Sprague-Dawley rats (SD-T) treated with the Ang type 1 receptor (AT(1)R) blocker telmisartan (2 mg · kg(-1) · day(-1)) or vehicle (R2-C; SD-C) for 3 weeks to examine PT structure and function.
RESULTS: Ren2 rats displayed increased systolic blood pressure, proteinuria and increased PT oxidant stress and remodeling. There were parallel increases in kidney injury molecule-1 and reductions in neprilysin and megalin with associated ultrastructural findings of decreased clathrin-coated pits, endosomes, and vacuoles. Ren2 rats displayed increased Serine(2448) phosphorylation of mTOR and downstream S6K1, in concert with ultrastructural basement membrane thickening, tubulointerstitial fibrosis and loss of the adhesion molecule N-cadherin. Telmisartan treatment attenuated proteinuria as well as the biochemical and tubulointerstitial structural abnormalities seen in the Ren2 rats.
CONCLUSIONS: Our observations suggest that Ang II activation of the AT(1)R contributes to PT brush border injury and remodeling, in part, due to enhanced mTOR/S6K1 signaling which promotes tubulointerstitial fibrosis through loss of N-cadherin.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21720156      PMCID: PMC3130895          DOI: 10.1159/000329327

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  43 in total

Review 1.  Integrins in kidney development, function, and disease.

Authors:  J A Kreidberg; J M Symons
Journal:  Am J Physiol Renal Physiol       Date:  2000-08

2.  Regulation of receptor-mediated endocytosis by Rho and Rac.

Authors:  C Lamaze; T H Chuang; L J Terlecky; G M Bokoch; S L Schmid
Journal:  Nature       Date:  1996-07-11       Impact factor: 49.962

3.  Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis.

Authors:  K Jinde; D J Nikolic-Paterson; X R Huang; H Sakai; K Kurokawa; R C Atkins; H Y Lan
Journal:  Am J Kidney Dis       Date:  2001-10       Impact factor: 8.860

4.  Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat.

Authors:  Carlos M Ferrario; David B Averill; K Bridget Brosnihan; Mark C Chappell; Samy S Iskandar; Richard H Dean; Debra I Diz
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

Review 5.  The tandem endocytic receptors megalin and cubilin are important proteins in renal pathology.

Authors:  Pierre J Verroust; Henrik Birn; Rikke Nielsen; Renata Kozyraki; Erik Ilsø Christensen
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

6.  Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells.

Authors:  Yves Gorin; Jill M Ricono; Nam-Ho Kim; Basant Bhandari; Goutam Ghosh Choudhury; Hanna E Abboud
Journal:  Am J Physiol Renal Physiol       Date:  2003-08

7.  ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells.

Authors:  Sassan Hafizi; Xuemin Wang; Adrian H Chester; Magdi H Yacoub; Christopher G Proud
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-09       Impact factor: 4.733

Review 8.  Reactive oxygen species and matrix remodeling in diabetic kidney.

Authors:  Hunjoo Ha; Hi Bahl Lee
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121

9.  Loss of N-cadherin and alpha-catenin in the proximal tubules of aging male Fischer 344 rats.

Authors:  Ki-Yoon Jung; Dana Dean; Jing Jiang; Susan Gaylor; William H Griffith; Robert C Burghardt; Alan R Parrish
Journal:  Mech Ageing Dev       Date:  2004-06       Impact factor: 5.432

10.  Ischemia-reperfusion induces glomerular and tubular activation of proinflammatory and antiapoptotic pathways: differential modulation by rapamycin.

Authors:  Antonia Loverre; Pasquale Ditonno; Antonio Crovace; Loreto Gesualdo; Elena Ranieri; Paola Pontrelli; Giovanni Stallone; Barbara Infante; Antonio Schena; Salvatore Di Paolo; Carmen Capobianco; Michele Ursi; Silvano Palazzo; Michele Battaglia; Francesco Paolo Selvaggi; Francesco Paolo Schena; Giuseppe Grandaliano
Journal:  J Am Soc Nephrol       Date:  2004-10       Impact factor: 10.121

View more
  28 in total

1.  Over-nutrition contributes to tubulointerstitial fibrosis by targeting nutrient-sensing kinases: role for the mTOR/S6K pathway.

Authors:  Ravi Nistala; James R Sowers; Adam Whaley-Connell
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

2.  Renin angiotensin system modulates mTOR pathway through AT2R in HIVAN.

Authors:  Partab Rai; Rivka Lederman; Shabirul Haque; Shabina Rehman; Viki Kumar; Kavithalakshmi Sataranatrajan; Ashwani Malhotra; Balakuntalam S Kasinath; Pravin C Singhal
Journal:  Exp Mol Pathol       Date:  2014-04-21       Impact factor: 3.362

Review 3.  Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II.

Authors:  Ravi Nistala; Adam Whaley-Connell
Journal:  Mol Cell Endocrinol       Date:  2013-02-15       Impact factor: 4.102

Review 4.  Overnutrition, mTOR signaling, and cardiovascular diseases.

Authors:  Guanghong Jia; Annayya R Aroor; Luis A Martinez-Lemus; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-24       Impact factor: 3.619

5.  Mineralocorticoid receptor-dependent proximal tubule injury is mediated by a redox-sensitive mTOR/S6K1 pathway.

Authors:  Adam T Whaley-Connell; Javad Habibi; Ravi Nistala; Vincent G DeMarco; Lakshmi Pulakat; Melvin R Hayden; Tejaswini Joginpally; Carlos M Ferrario; Alan R Parrish; James R Sowers
Journal:  Am J Nephrol       Date:  2011-12-24       Impact factor: 3.754

6.  Valsartan ameliorates high glucose-induced peritoneal fibrosis by blocking mTORC1 signaling.

Authors:  Jing Liu; Yuan Feng; Cheng Sun; Wei Zhu; Qing-Yan Zhang; Bo Jin; Qiu-Yuan Shao; Yang-Yang Xia; Peng-Fei Xu; Miao Zhang; Chun-Ming Jiang
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-14

7.  Angiotensin II mediates cell survival through upregulation and activation of the serum and glucocorticoid inducible kinase 1.

Authors:  Rebekah Baskin; Peter P Sayeski
Journal:  Cell Signal       Date:  2011-09-22       Impact factor: 4.315

8.  Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats.

Authors:  Norihito Moniwa; Jasmina Varagic; Sarfaraz Ahmad; Jessica L VonCannon; Carlos M Ferrario
Journal:  Ther Adv Cardiovasc Dis       Date:  2012-01-05

9.  Telmisartan Protects Against Aluminum-Induced Alzheimer-like Pathological Changes in Rats.

Authors:  Mona Khalifa; Marwa M Safar; Rania M Abdelsalam; Hala F Zaki
Journal:  Neurotox Res       Date:  2019-07-22       Impact factor: 3.911

Review 10.  Insulin Resistance in Kidney Disease: Is There a Distinct Role Separate from That of Diabetes or Obesity?

Authors:  Adam Whaley-Connell; James R Sowers
Journal:  Cardiorenal Med       Date:  2017-09-30       Impact factor: 2.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.